Alzheimer’s Disease: Advancing Early Diagnosis and Multidisciplinary Care

This publication is sponsored by Eli Lilly and Company.

This actionable resource outlines multidisciplinary strategies from the University of Cincinnati and Duke University for developing and implementing care pathways for patients with early symptomatic Alzheimer’s disease eligible for amyloid-targeting therapies, including administrative alignment, electronic health record resource integration, and ongoing care pathway evaluation.